Criteo S.A. (CRTO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRTO SEC filings page.
Criteo S.A. (CRTO) reported $1.9B in revenue for fiscal year 2025, up 0.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue stayed nearly flat while margin expansion and cash conversion made FY2025 materially more profitable.
Revenue was essentially flat from FY2024 to FY2025, yet gross margin rose from50.8% to54.0% , indicating profitability improved through lower direct costs or a more favorable revenue mix rather than added volume. Operating margin widened to10.4% , showing the gross-profit improvement reached operating earnings even with R&D at$283M .
Operating cash flow rose to
Liabilities declined from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Criteo S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Criteo S.A. has an operating margin of 10.4%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 59/100, indicating healthy but not exceptional operating efficiency. This is up from 7.8% the prior year.
Criteo S.A.'s revenue grew a modest 0.6% year-over-year to $1.9B. This slow but positive growth earns a score of 30/100.
Criteo S.A. has a moderate D/E ratio of 0.88. This balance of debt and equity financing earns a leverage score of 50/100.
Criteo S.A.'s current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.
Criteo S.A. has a free cash flow margin of 10.7%, earning a moderate score of 64/100. The company generates positive cash flow after capital investments, but with room for improvement.
Criteo S.A. earns a strong 13.0% return on equity (ROE), meaning it generates $13 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 68/100. This is up from 11.0% the prior year.
Criteo S.A. scores 2.14, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Criteo S.A. passes 8 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Criteo S.A. generates $2.09 in operating cash flow ($311.2M OCF vs $149.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Criteo S.A. earns $82.39 in operating income for every $1 of interest expense ($202.8M vs $2.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Criteo S.A. generated $428.0M in revenue in Q2 2026. This represents a decrease of 11.3% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.
Criteo S.A. reported $11.2M in net income in Q2 2026. This represents a decrease of 47.3% from the same quarter a year earlier. Against the prior quarter it is up 43.1%.
Criteo S.A. earned $0.22 per diluted share (EPS) in Q2 2026. This represents a decrease of 43.6% from the same quarter a year earlier. Against the prior quarter it is up 46.7%.
Not reported for Q2 2026.
Cash & Balance Sheet
Criteo S.A. recorded an outflow of $37.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is down 347.0%.
Criteo S.A. held $252.2M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Criteo S.A.'s gross margin was 51.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.
Criteo S.A.'s operating margin was 3.5% in Q2 2026, reflecting core business profitability. This is down 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.
Criteo S.A.'s net profit margin was 2.6% in Q2 2026, showing the share of revenue converted to profit. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.
Criteo S.A.'s ROE was 1.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Capital Allocation
Criteo S.A. invested $71.9M in research and development in Q2 2026. This represents a decrease of 9.6% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.
Criteo S.A. spent $30.4M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 37.2% from the same quarter a year earlier. Against the prior quarter it is down 2.0%.
Criteo S.A. invested $58.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 65.2% from the same quarter a year earlier. Against the prior quarter it is up 77.3%.
CRTO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $428.0M-11.3% | $424.6M-5.9% | N/A | $482.7M+2.4% | $451.4M+0.3% | $553.0M-2.3% | $458.9M-2.2% | $471.3M+0.5% |
| Cost of Revenue | $172.5M-9.5% | $174.3M-6.8% | N/A | $190.6M-6.7% | $187.1M-4.6% | $218.6M-12.5% | $192.8M-13.9% | $204.2M-10.7% |
| Gross Profit | $222.2M-14.0% | $222.7M-6.0% | N/A | $258.5M+11.0% | $237.0M+9.1% | $301.0M+8.8% | $231.9M+13.1% | $232.8M+16.5% |
| R&D Expenses | $71.9M-9.6% | $69.7M+14.7% | N/A | $79.6M+33.5% | $60.7M-9.1% | $67.6M+39.6% | $85.3M+36.4% | $59.6M-12.0% |
| SG&A Expenses | $49.7M+23.6% | $45.2M+15.3% | N/A | $40.2M-2.3% | $39.2M-17.0% | $41.5M-1.6% | $46.2M+26.3% | $41.2M+122.3% |
| Operating Income | $15.0M-50.7% | $10.4M-78.4% | N/A | $30.5M-17.6% | $48.2M+365.2% | $94.5M+7.0% | $9.6M-16.0% | $36.9M+3751.7% |
| Interest Expense | $660K+0.5% | $764K+77.7% | N/A | $657K+60.6% | $430K+1.7% | $487K-34.5% | $505K+15.6% | $409K-29.1% |
| Income Tax | $3.6M-37.6% | $3.7M-64.7% | N/A | $5.7M-33.3% | $10.5M+252.2% | $24.8M+13.8% | $3.5M+88.3% | $8.6M+697.3% |
| Net Income | $11.2M-47.3% | $7.8M-79.4% | N/A | $21.3M-21.3% | $37.9M+423.6% | $74.5M+18.7% | $6.2M-9.8% | $27.0M+1038.4% |
| EPS (Basic) | $0.23-42.5% | $0.16-77.1% | N/A | $0.40-18.4% | $0.70+438.5% | $1.30+19.3% | $0.11-8.3% | $0.49+1080.0% |
| EPS (Diluted) | $0.22-43.6% | $0.15-77.3% | N/A | $0.39-15.2% | $0.66+450.0% | $1.21+18.6% | $0.11-8.3% | $0.46+1020.0% |
| Diluted Shares (Avg) | 51M-8.3% | 51M-10.9% | N/A | 55M-6.5% | 57M-3.6% | N/A | 58M-2.9% | 59M+5.5% |
Not reported in any period shown, so not listed: EBITDA.
CRTO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0B-4.9% | $2.1B-2.6% | $2.2B-2.9% | $2.1B-2.5% | $2.1B-3.5% | $2.3B-5.2% | $2.2B+3.2% | $2.2B+1.9% |
| Current Assets | $873.1M-14.9% | $940.3M-13.3% | $1.1B-12.4% | $1.0B-9.9% | $1.1B-6.4% | $1.2B-6.7% | $1.1B+6.1% | $1.1B+7.6% |
| Cash & Equivalents | $252.2M+22.6% | $320.0M+11.9% | $342.0M+17.7% | $205.7M-5.1% | $285.9M+7.1% | $290.7M-13.6% | $208.7M+7.1% | $216.7M-2.9% |
| Short-Term Investments | $28.1M+56.9% | $28.3M+3.8% | $23.2M-11.4% | $17.9M+8.5% | $27.3M+143.2% | $26.2M+339.6% | $23.0M+9.1% | $16.5M-22.1% |
| Accounts Receivable | $456.0M-31.7% | $448.3M-30.7% | $582.1M-27.3% | $667.8M+5.5% | $647.1M+6.0% | $800.9M+3.3% | $646.3M+3.5% | $632.7M+10.3% |
| Long-Term Investments | $22.8M+29.6% | $23.0M+41.7% | $23.5M+50.8% | $17.6M+228.4% | $16.2M+50.1% | $15.6M-6.0% | $5.6M-64.8% | $5.4M-67.2% |
| Goodwill | $531.8M-0.6% | $532.5M+2.2% | $535.8M+4.0% | $534.9M+2.9% | $521.1M0.0% | $515.2M-1.7% | $526.6M+1.5% | $519.9M-0.5% |
| Total Liabilities | $846.7M-14.2% | $902.6M-12.2% | $1.0B-14.3% | $986.6M-9.9% | $1.0B-9.3% | $1.2B-7.4% | $1.1B+1.5% | $1.1B+0.9% |
| Current Liabilities | $677.7M-18.7% | $737.0M-16.9% | $844.7M-19.3% | $833.5M-12.8% | $886.8M-10.9% | $1.0B-8.2% | $974.6M+1.4% | $955.9M+0.7% |
| Non-Current Liabilities | $168.9M+10.4% | $165.6M+17.5% | $170.8M+23.1% | $153.1M+10.3% | $140.9M+1.6% | $138.8M-0.9% | $148.2M+2.3% | $138.8M+1.8% |
| Total Equity | $1.1B+3.5% | $1.1B+6.4% | $1.1B+9.5% | $1.1B+4.4% | $1.1B+2.2% | $1.0B-2.8% | $1.1B+4.6% | $1.0B+3.0% |
| Retained Earnings | $608.3M-3.0% | $635.9M+4.7% | $630.8M+10.3% | $627.1M+16.7% | $607.4M+11.8% | $571.7M+2.9% | $557.1M+10.5% | $537.2M+1.8% |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
CRTO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $20.3M+1553.0% | $48.2M-22.7% | N/A | -$1.4M-108.1% | $62.3M+344.8% | $169.5M+5.0% | $57.5M+193.2% | $17.2M+1194.2% |
| Stock-Based Compensation | $16.4M-24.5% | $13.3M-13.4% | N/A | $21.8M | $15.4M-43.5% | N/A | N/A | N/A |
| Capital Expenditures | $58.2M+65.2% | $32.8M+92.2% | N/A | $35.3M+66.1% | $17.1M+23.5% | N/A | N/A | $21.2M |
| Free Cash Flow | -$37.9M-3.5% | $15.4M-66.1% | N/A | -$36.6M-806.7% | $45.3M+26056.1% | N/A | N/A | -$4.0M |
| Investing Cash Flow | -$57.8M-138.8% | -$37.9M-116.2% | N/A | -$24.2M-13.8% | -$17.5M-26.2% | -$38.9M-762.7% | -$23.8M-50.1% | -$21.3M+59.3% |
| Financing Cash Flow | -$30.7M+36.6% | -$31.3M+42.9% | N/A | -$48.3M-21.1% | -$54.8M+11.9% | -$116.1M-418.6% | -$52.3M-81.8% | -$39.9M-67.0% |
| Share Buybacks | $30.4M-37.2% | $31.0M-44.9% | N/A | $48.3M+19.8% | $56.2M-9.6% | $67.1M+203.2% | $55.0M+93.1% | $40.4M+69.3% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid.
CRTO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.9%-1.6pp | 52.4%0.0pp | N/A | 53.6%+4.2pp | 52.5%+4.2pp | 54.4%+5.6pp | 50.5%+6.8pp | 49.4%+6.8pp |
| Operating Margin | 3.5%-2.8pp | 2.5%-8.2pp | N/A | 6.3%-1.5pp | 10.7%+8.4pp | 17.1%+1.5pp | 2.1%-0.4pp | 7.8%+7.6pp |
| Net Margin | 2.6%-1.8pp | 1.8%-6.6pp | N/A | 4.4%-1.3pp | 8.4%+6.8pp | 13.5%+2.4pp | 1.4%-0.1pp | 5.7%+6.3pp |
| Return on Equity | 1.0%-1.0pp | 0.7%-2.9pp | N/A | 1.9%-0.6pp | 3.6%+2.9pp | 7.1%+1.3pp | 0.6%-0.1pp | 2.6%+2.9pp |
| Return on Assets | 0.6%-0.4pp | 0.4%-1.4pp | N/A | 1.0%-0.2pp | 1.8%+1.4pp | 3.3%+0.7pp | 0.3%0.0pp | 1.2%+1.4pp |
| Current Ratio | 1.29+0.1x | 1.28+0.1x | 1.27+0.1x | 1.230.0x | 1.22+0.1x | 1.170.0x | 1.17+0.1x | 1.19+0.1x |
| Debt-to-Equity | 0.75-0.2x | 0.80-0.2x | 0.88-0.2x | 0.91-0.1x | 0.97-0.1x | 1.13-0.1x | 1.070.0x | 1.050.0x |
| Asset Turnover | 0.210.0x | 0.200.0x | N/A | 0.230.0x | 0.210.0x | 0.240.0x | 0.210.0x | 0.220.0x |
| FCF Margin | -8.9%-1.3pp | 3.6%-6.4pp | N/A | -7.6%-6.7pp | 10.0%+10.0pp | N/A | N/A | -0.9% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Criteo S.A. CRTO | FY2025 | $1.9B | $149.0M | 7.7% | $721.7M | 51/100 |
| Integral Ad Science Holding Corp. IAS | FY2024 | $530.1M | $37.8M | 7.1% | $1.7B | 69/100 |
| QuinStreet, Inc. QNST | FY2026 | $1.3B | $81.2M | 6.3% | $856.6M | 56/100 |
| Emerald Holding, Inc. EEX | FY2025 | $463.4M | -$30.7M | -6.6% | $997.5M | 42/100 |
| Ziff Davis, Inc. ZD | FY2025 | $1.5B | $47.4M | 3.3% | $1.9B | 60/100 |
| Stagwell Inc. STGW | FY2025 | $2.9B | $30.6M | 1.1% | $2.0B | 39/100 |
Where Criteo S.A. Ranks
Frequently Asked Questions
What is Criteo S.A.'s annual revenue?
Criteo S.A. (CRTO) reported $1.9B in total revenue for fiscal year 2025. This represents a 0.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Criteo S.A.'s revenue growing?
Criteo S.A. (CRTO) revenue grew by 0.6% year-over-year, from $1.9B to $1.9B in fiscal year 2025.
Is Criteo S.A. profitable?
Yes, Criteo S.A. (CRTO) reported a net income of $149.0M in fiscal year 2025, with a net profit margin of 7.7%.
What is Criteo S.A.'s EBITDA?
Criteo S.A. (CRTO) had EBITDA of $325.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Criteo S.A.'s gross margin?
Criteo S.A. (CRTO) had a gross margin of 54.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Criteo S.A.'s operating margin?
Criteo S.A. (CRTO) had an operating margin of 10.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Criteo S.A.'s net profit margin?
Criteo S.A. (CRTO) had a net profit margin of 7.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Criteo S.A.'s return on equity (ROE)?
Criteo S.A. (CRTO) has a return on equity of 13.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Criteo S.A.'s free cash flow?
Criteo S.A. (CRTO) generated $208.5M in free cash flow during fiscal year 2025. This represents a 15.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Criteo S.A.'s operating cash flow?
Criteo S.A. (CRTO) generated $311.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Criteo S.A.'s total assets?
Criteo S.A. (CRTO) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Criteo S.A.'s capital expenditures?
Criteo S.A. (CRTO) invested $102.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Criteo S.A. spend on research and development?
Criteo S.A. (CRTO) invested $283.3M in research and development during fiscal year 2025.
What is Criteo S.A.'s current ratio?
Criteo S.A. (CRTO) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.
What is Criteo S.A.'s debt-to-equity ratio?
Criteo S.A. (CRTO) had a debt-to-equity ratio of 0.88 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Criteo S.A.'s return on assets (ROA)?
Criteo S.A. (CRTO) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Criteo S.A.'s P/E ratio?
Criteo S.A. (CRTO) trades at 4.8x earnings, its market capitalization divided by net income of $149.0M net income, FY2025. The market capitalization is $721.7M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Criteo S.A.'s price-to-sales ratio?
Criteo S.A. (CRTO) trades at 0.4x sales, its market capitalization divided by revenue of $1.9B revenue, FY2025. The market capitalization is $721.7M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Criteo S.A.'s Altman Z-Score?
Criteo S.A. (CRTO) has an Altman Z-Score of 2.14, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Criteo S.A.'s Piotroski F-Score?
Criteo S.A. (CRTO) has a Piotroski F-Score of 8 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Criteo S.A.'s earnings high quality?
Criteo S.A. (CRTO) has an earnings quality ratio of 2.09x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Criteo S.A. cover its interest payments?
Criteo S.A. (CRTO) has an interest coverage ratio of 82.39x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Criteo S.A.?
Criteo S.A. (CRTO) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.